Page last updated: 2024-09-03

marimastat and methane

marimastat has been researched along with methane in 1 studies

Compound Research Comparison

Studies
(marimastat)
Trials
(marimastat)
Recent Studies (post-2010)
(marimastat)
Studies
(methane)
Trials
(methane)
Recent Studies (post-2010) (methane)
215285339,14224926,184

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Begay, JG; Campen, MJ; Denson, JL; Erdely, A; Fraser, K; Herbert, G; Hunter, R; Lucas, SN; Mostovenko, E; Ottens, AK; Salazar, R; Wang, T; Young, TL; Zychowski, K1

Other Studies

1 other study(ies) available for marimastat and methane

ArticleYear
Pulmonary delivery of the broad-spectrum matrix metalloproteinase inhibitor marimastat diminishes multiwalled carbon nanotube-induced circulating bioactivity without reducing pulmonary inflammation.
    Particle and fibre toxicology, 2021, 09-08, Volume: 18, Issue:1

    Topics: Animals; Bronchoalveolar Lavage Fluid; Endothelial Cells; Hydroxamic Acids; Lung; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Nanotubes, Carbon; Pneumonia

2021